同型半胱氨酸与IVF/ICSI结局的关联:按MTHFR C677T多态性分层的前瞻性队列研究
该前瞻性队列研究纳入2015年6月至2018年3月首次接受IVF/ICSI治疗的1011例不孕女性,探讨血清同型半胱氨酸(Hcy)与IVF/ICSI结局的关联并按MTHFR C677T多态性分层。结果显示Hcy与临床妊娠率和植入率显著负相关,调整混杂因素后高Hcy与妊娠失败风险升高相关,且该风险仅在MTHFR C677T TT基因型女性中显著。
要点
- 血清Hcy浓度与临床妊娠率和植入率显著负相关。
- 高Hcy女性妊娠失败风险升高,尤其MTHFR C677T TT基因型。
- Hcy与卵巢刺激结局及新生儿结局无显著关联。
核心结论
- Hcy与首次IVF/ICSI周期的临床妊娠率和植入率高度负相关,尤其在MTHFR C677T TT基因型女性中。
研究设计与样本
- 前瞻性队列研究,纳入2015年6月至2018年3月于国际和平妇幼保健院首次接受IVF/ICSI治疗的1011例不孕女性。
主要发现
- 血清总Hcy浓度与临床妊娠和植入率显著负相关。
- 调整母亲和父亲年龄、教育水平、母亲BMI、FSH和雌二醇浓度后,逻辑回归显示高Hcy女性妊娠失败风险更高。
- 按MTHFR C677T多态性分层并调整混杂因素后,高Hcy女性妊娠失败风险升高和植入率显著降低仅存在于MTHFR C677T TT基因型。
- Hcy浓度与其他卵巢刺激结局(获卵数、MII卵数、受精率、卵裂率、优质胚胎率)或新生儿结局(早产、分娩孕周、剖宫产、出生体重、小于胎龄儿、大于胎龄儿或出生缺陷)无显著关联。
临床怎么用
- 对首次IVF/ICSI治疗的不孕女性,尤其MTHFR C677T TT基因型者,可关注血清Hcy水平以评估妊娠失败风险。
局限性
- 进一步研究应考虑移植胚胎阶段、叶酸代谢其他因素、植入前遗传学检测等影响生殖结局的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the association between homocysteine (Hcy) and IVF/intracytoplasmic sperm injection (ICSI) outcomes, stratified by methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms? DESIGN: This prospective cohort study recruited 1011 infertile women undergoing IVF/ICSI treatment for the first time at the International Peace Maternity and Child Health Hospital between June 2015 and March 2018. RESULTS: The concentration of total serum Hcy was significantly negatively associated with clinical pregnancy and implantation rate. When adjusted for maternal and paternal age and educational level, maternal body mass index, and FSH and oestradiol concentrations, logistic regression analysis showed that women with higher Hcy had a higher risk of unsuccessful pregnancy. After stratification by MTHFR C677T polymorphisms and adjustment for confounding factors, a higher risk of unsuccessful pregnancy and a significantly lower implantation rate only existed in women with higher Hcy concentration in the MTHFR C677T TT genotype. There was no significant association between Hcy concentrations and other ovarian stimulation outcomes (oocytes retrieved, metaphase II stage oocytes, fertilization rate, cleavage rate, high-quality embryo rate) or neonatal outcomes (preterm birth, gestational age at delivery, Caesarean section, birthweight, small for gestational age, large for gestational age or birth defects). CONCLUSIONS: Hcy is highly negatively associated with clinical pregnancy and implantation rate during the first IVF/ICSI cycle, especially in women carrying the MTHFR C677T TT genotype. Other factors with impacts on reproductive outcomes, such as stage of embryo transferred, other factors involved in folate metabolism, preimplantation genetic testing, etc., should be taken into account in further research.
引用
- Chen L, Chen H, Wang X, et al. Association of homocysteine with IVF/ICSI outcomes stratified by MTHFR C677T polymorphisms: a prospective cohort study. Reprod Biomed Online. 2021. PMID: 34016520. doi:10.1016/j.rbmo.2021.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。